# US 2025/0082690 A1 · Sheet-shaped cell culture for treating liver dysfunction

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082690 A1
- Document ID: US20250082690A1
- Status: Published application
- Kind: A1
- Application number: 18/767,567
- Filed: 2024-07-09
- Published: 2025-03-13
- Earliest claimed: 2022-01-14
- Assignees: Terumo Kabushiki Kaisha; Osaka University
- Applicants: Terumo Kabushiki Kaisha; Osaka University
- Inventors: Hidetoshi EGUCHI; Yoshito TOMIMARU; Shigeru MIYAGAWA; Keisuke TOYA; Fumiya OHASHI
- Web page: https://patentgrep.com/patent/US20250082690A1

## CPC

- A61K 35/34: Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44)
- A61L 27/3826: {Muscle cells, e.g. smooth muscle cells}
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 35/00: Antineoplastic agents
- C12N 5/0658: {Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts}
- A61L 2430/28: for liver reconstruction
- C12N 2539/10: Coating allowing for selective detachment of cells, e.g. thermoreactive coating
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A sheet-shaped cell culture comprising skeletal myoblasts for treating liver dysfunction or improving liver function. A method for producing the sheet-shaped cell culture, including a step of seeding a cell population comprising skeletal myoblasts on a culture substrate, a step of forming a sheet of the cell population into a sheet to form a sheet-shaped cell culture, and a step of detaching the formed sheet-shaped cell culture from the culture substrate. A method for treating liver dysfunction, including a step of applying the sheet-shaped cell culture to a site exhibiting the liver dysfunction.

## Claims

### Claim 1

A sheet-shaped cell culture comprising skeletal myoblasts for treating liver dysfunction or improving liver function.

### Claim 2 (depends on 1)

The sheet-shaped cell culture of claim 1, wherein the liver dysfunction is hepatitis, liver fibrosis, liver cirrhosis, liver cancer, or liver failure.

### Claim 3 (depends on 1)

The sheet-shaped cell culture of claim 1, wherein the liver dysfunction is liver cirrhosis.

### Claim 4 (depends on 1)

The sheet-shaped cell culture of claim 1, wherein the liver dysfunction is liver cancer.

### Claim 5 (depends on 4)

The sheet-shaped cell culture of claim 4, for application to a liver after liver cancer resection.

### Claim 6 (depends on 1)

The sheet-shaped cell culture of claim 1, for promoting proliferation of liver cells, regeneration of a liver tissue and/or angiogenesis.

### Claim 7 (depends on 1)

The sheet-shaped cell culture of claim 1, for suppressing liver fibrosis.

### Claim 8 (depends on 1)

The sheet-shaped cell culture of claim 1, for treating liver dysfunction via cytokine production.

### Claim 9 (depends on 1)

The sheet-shaped cell culture of claim 1, further comprising a reinforcement layer comprising a gel and/or a polymer.

### Claim 10 (depends on 1)

A method for producing the sheet-shaped cell culture of claim 1, the method comprising:
seeding a cell population comprising skeletal myoblasts on a culture substrate;
forming a sheet of the cell population seeded to form a sheet-shaped cell culture; and
detaching the formed sheet-shaped cell culture from the culture substrate.

### Claim 11 (depends on 1)

A method for treating liver dysfunction, comprising, applying the sheet-shaped cell culture of claim 1 to a site exhibiting the liver dysfunction.

### Claim 12 (depends on 11)

The method of claim 11, wherein the step of applying the sheet-shaped cell culture to a site exhibiting liver dysfunction is performed by implanting the sheet-shaped cell culture onto a liver surface with an implantation device.

### Claim 13

A method for producing a sheet-shaped cell culture medium for application to an organ, comprising:
seeding a cell population comprising skeletal myoblasts on a culture substrate;
forming a sheet of the cell population seeded to form a sheet-shaped cell culture; and
applying a reinforcement layer, a graft, or both to the sheet-shaped cell culture to form the sheet-shaped cell culture medium, wherein the sheet-shaped cell culture medium is free of a scaffold.

### Claim 14 (depends on 13)

The method of claim 13, wherein the sheet-shaped cell culture comprises one or more layers of cells arranged in a substantially horizontal orientation, wherein the cells comprise the skeletal myoblasts.

### Claim 15 (depends on 13)

The method of claim 13, wherein the sheet-shaped cell culture comprises a substantially uniform thickness ranging from about 30 μm to about 1000 μm.

### Claim 16 (depends on 13)

The method of claim 13, wherein the sheet-shaped cell culture comprises an area ranging from about 1 cm2 to about 200 cm2.

### Claim 17 (depends on 13)

The method of claim 13, wherein the sheet-shaped cell culture further comprises adhesive somatic cells, stem cells other than skeletal myoblasts, or both in combination with the skeletal myoblasts, and wherein the sheet-shaped cell culture comprises at least about 50% of the skeletal myoblasts.

### Claim 18

A method for treating organ dysfunction, comprising:
identifying a site of dysfunction in an organ;
producing a cell culture medium comprising one or more layers based at least in part on the identifying, wherein at least one layer of the one or more layers comprises skeletal myoblasts; and
applying the cell culture medium to the site exhibiting the organ dysfunction.

### Claim 19 (depends on 18)

The method of claim 18, wherein producing the cell culture medium, comprises:
seeding a cell population comprising the skeletal myoblasts on a culture substrate; and
forming a sheet of the cell population seeded to form a sheet-shaped cell culture.

### Claim 20 (depends on 19)

The method of claim 19, wherein producing the cell culture medium further comprises:
applying a reinforcement layer, a graft, or both to the sheet-shaped cell culture to form the cell culture medium, wherein the cell culture medium is free of a scaffold, and wherein the at least one layer of the one or more layers comprising the skeletal myoblasts, a layer comprising the graft, or a combination thereof is in direct contact with the site of organ dysfunction.
